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Abstract
Purpose—To evaluate the association between physical activity (PA) across the menstrual cycle
and reproductive function.
Methods—The BioCycle Study (2005–2007) followed 259, healthy premenopausal women not
using hormonal contraceptives for up to two menstrual cycles (N=509 cycles). Serum leptin,
estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, and testosterone were
measured five to eight times per cycle. Linear mixed models were used to estimate the effect of
past-week PA (measured four times during each cycle) on hormone levels. Past-week PA was
categorized into tertiles based on metabolic equivalent [MET]-h/week (cut-points were 15.3 and
35.7). Risk ratios for sporadic anovulation were estimated using generalized linear models.
Analyses adjusted for habitual PA (assessed at baseline), body mass index, race, age, and
perceived stress. Linear mixed models used inverse probability weights to control for concurrent
reproductive hormones and caloric intake.
Results—High past-week PA was inversely associated with leptin (−6.6%, 95% confidence
interval [−10.6, −2.5]) and luteal phase progesterone (−22.1% [−36.2, −4.7]) as compared with
low past-week PA. High past-week PA was not significantly associated with sporadic anovulation
(adjusted risk ratio=1.5 [0.6, 3.4]).
© 2013 Elsevier Inc. All rights reserved.
Corresponding Author’s and Request for Reprints Contact Information: Enrique Schisterman, Ph. D., Eunice Kennedy Shriver
National Institute of Child Health and Human Development, NIH, MSC 7510, 6100 Executive Blvd., 7B03, Bethesda, MD
20892-7510, Tel: 301-435-6893, Fax: 301-402-2084. Author responsible for correspondence related to the manuscript: Katherine
Ahrens, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, MSC 7510, 6100
Executive Blvd., 7B03, Bethesda, MD 20892-7510, Tel: 301-594-9149, Fax: 301-402-2084, katherine.ahrens@nih.gov.
Conflicts of interest
We declare we have no conflicts of interest.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Ann Epidemiol. Author manuscript; available in PMC 2015 February 01.
Published in final edited form as:













Conclusions—High levels of PA were modestly associated with changes in select hormones,
but not sporadic anovulation among moderate to highly active premenopausal women.
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INTRODUCTION
Physical activity (PA) is beneficial for women’s health as it is associated with a decreased
risk of cardiovascular disease; breast and colon cancers; type 2 diabetes; osteoporosis; and
other adverse health outcomes. [1] The U.S. Department of Health & Human Services
recommends that individuals engage in at least 150 minutes of moderate-intensity PA per
week in order to gain these important health benefits. [1] As the majority (~70%) of
reproductive-age women report meeting these guidelines, [2] it is important to understand
the effects of PA on reproductive hormones and ovulation, which can subsequently
influence fertility outcomes.
There is evidence suggesting that high-intensity activity is associated with menstrual
dysfunction and subfertility among high-performance female athletes. [3] Previous studies
have found that high-intensity activity is associated with amenorrhea, oligomenorrhea, luteal
phase deficiency, and anovulation, likely through disturbances of the hypothalamic-
pituitary-adrenal axis. [3, 4] It has been hypothesized that suppression of gonadotropin-
releasing hormone resulting from exercise-associated hypothalamic dysfunction can delay
menarche and disrupt menstrual cycle patterns by limiting the secretion of luteinizing
hormone (LH) and follicle-stimulating hormone (FSH). [3, 5]
While much is known about PA and reproductive function among athletes, less is known
about this association among more moderately active women. Several studies have
examined the association between moderate levels of PA and menstrual cycle characteristics
[6–8] or urinary and salivary hormone concentrations. [9–12] However, fewer studies have
assessed the effect of PA on circulating hormone concentrations, [13–15] and they were
limited by assessing PA at only one time point and collecting blood at most two times across
a menstrual cycle.
The primary objective of our study was to examine the association between PA and
reproductive hormones, including estradiol, progesterone, LH, FSH, testosterone, and leptin,
across the menstrual cycle. Our secondary objective was to examine the association between
PA and the risk of sporadic anovulation. The effects of PA on reproductive function have




The BioCycle Study, conducted in 2005–2007, was a cohort study of 259 regularly
menstruating, healthy premenopausal women from Western New York who were followed
over one (n=9) or two (n=250) menstrual cycles. Women were ineligible for the study if
they used oral contraceptives or medications for a chronic medical condition; were recently
pregnant or breastfeeding; had been diagnosed with a menstrual or ovulatory disorder;
planned to consume a restricted diet in the next 3 months or self-reported their body mass
index (BMI) as less than 18 or greater than 35 kg/m2 at screening. Additional information
about the study population is described elsewhere. [16] Among the 449 women screened for
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study participation, 319 met the eligibility criteria, 276 enrolled in the study, and 17
withdrew after enrollment. The University at Buffalo Health Sciences Institutional Review
Board (IRB) approved the study and served as the IRB designated by the National Institutes
of Health for this study under a reliance agreement. All participants provided written
informed consent.
Measures
Reproductive hormones, anovulation and menstrual cycle characteristics—
Women provided morning fasting blood samples five to eight times per cycle. Fertility
monitors (Clearblue Easy Fertility Monitor; Inverness Medical, Waltham, Massachusetts)
were used to time mid-cycle visits, with the remaining visits scheduled according to an
algorithm that considered each woman’s typical cycle length. [17] For a standardized 28-day
menstrual cycle, blood samples were collected during the following expected phases:
menses (standardized day 2), follicular (standardized day 7), ovulatory (standardized days
12, 13, and 14), and luteal (standardized days 18, 22, and 27). Most women adhered to the
study protocol with 94% providing at least seven blood samples per cycle. Samples
(N=3,903) were processed according to standard protocols and frozen at −80°C within 90
minutes of phlebotomy. [18] They were then shipped on dry ice to analytical laboratories.
Samples from each participant were batched together and measured consecutively to limit
analytical variability.
Serum estradiol, progesterone, LH, and FSH levels were measured by solid-phase
competitive chemiluminescent enzymatic immunoassays on the DPC Immulite 2000
analyzer (Siemens Medical Solutions Diagnostics, Deerfield, Illinois) at Kaleida
Laboratories in Buffalo, New York. Serum total testosterone was measured by liquid
chromatography/tandem mass spectrometry using the Shimadzu Prominence Liquid
Chromatogram with an ABSceix 5500 tandem mass spectrometer at the Advanced Research
and Diagnostics Laboratory (Minneapolis, Minnesota). Increased sensitivity was achieved
by using 100% acetronitrile mobile phase B as the solvent gradient elution and adding a low
standard of 4 ng/dL. Serum leptin was measured by immunoassay using the Mercodia
Leptin ELISA (Mercodia AB, Uppsala, Sweden) by the Advanced Research and Diagnostics
Laboratory (see above). The interassay coefficients of variation were: < 10% for estradiol; <
14% for progesterone; < 4% for LH and FSH; and < 7% for testosterone. For leptin, select
batches of measurements were recalibrated post-assay by a calibration curve estimated from
all the calibration data. [19] The interassay coefficient of variation for leptin was < 10.2%
after recalibration. Values falling below the limit of detection (LOD) for each assay were
rare (< 3%) and were replaced with values equal to the LOD divided by the square root of
two. [20] All hormones were logarithmically transformed for normality.
Anovulatory cycles (n=42) were defined as cycles with a peak progesterone concentration ≤
5 ng/mL and no observed serum LH peak among samples collected during the latter half of
the cycle (i.e. days 22 and 27), which could indicate a missed luteal phase serum sample.
[21] Menstrual cycle characteristics (menstrual cycle length, follicular and luteal phase
length, menses length, and total blood loss during menses) were determined from fertility
monitor data, serum hormone levels, daily diaries, and pictograms for documenting total
blood loss. [21, 22]
Physical activity—There were three measures of self-reported PA: habitual PA (measured
at baseline using the long-form International Physical Activity Questionnaire, IPAQ [23,
24]); past-week PA (measured on days 2, 7, 14, and 22 using the short-form IPAQ, IPAQ-
SF); and daily vigorous PA (measured using a daily diary). Both IPAQs assessed the
duration and frequency of walking, moderate activity, and vigorous activity lasting for at
Ahrens et al. Page 3













least 10 minutes during the previous week, with the long-form IPAQ including additional
questions about specific types of activity. Total MET-hours per week (MET-h/week) were
calculated by summing the individual MET-h/week for each activity according to published
guidelines. [24] Past-week PA was further classified using the MET-h/week spent in
vigorous activity only and termed “vigorous past-week PA.” For daily vigorous PA,
participants were instructed to record the amount of time spent each day engaged in
vigorous activity, defined as “activities that take hard physical effort and make you breathe
much harder than normal.”
For the measure of habitual PA, women were categorized into tertiles based on MET-h/week
reported. For average past-week PA, the MET-h/week from the IPAQ-SFs were averaged
across each cycle and across the entire study period for each individual and then categorized
into tertiles, respectively. For the time-varying analyses, past-week PA was categorized into
tertiles based on the distribution of MET-h/week reported at each assessment, thus a woman
could be categorized as having high past-week PA at one assessment and low past-week PA
at another. In addition, tertile cut-points varied by assessment day as the distribution of
MET-h/week varied. Daily vigorous activity for the day prior to serum collection was
dichotomized as any versus none.
Covariates—Self-administered questionnaires were used to assess demographics, smoking
behavior, and perceived stress (measured by the 14-item Cohen Perceived Stress Scale) [25]
at study enrollment. BMI was calculated using weight and height as measured by trained
personnel at the baseline visit. Total caloric intake was assessed by four 24-hour dietary
recalls measured during each cycle.
Statistical analysis—Participant characteristics were compared by tertile of average past-
week PA across the study period with Fisher’s exact and ANOVA tests used to evaluate
differences. For repeated measures within individual women (i.e., from multiple cycles and
days), unadjusted linear mixed models were used to calculate means and assess differences
across PA tertiles for continuous variables and unadjusted generalized linear models were
used to assess differences for categorical variables. Unadjusted linear mixed models were
also used to assess differences in hormone concentrations among PA tertiles by standardized
serum collection day. The correlation structure was specified as unstructured for days and
first-order autoregressive for cycles.
The association between PA and reproductive hormone concentrations was estimated using
four PA exposure definitions: 1) habitual PA; 2) past-week PA; 3) vigorous past-week PA;
and 4) daily vigorous PA. Linear mixed models with random intercepts were used to assess
the effect of each PA definition on estradiol, progesterone, LH, FSH, testosterone, and leptin
levels across the menstrual cycle while accounting for variation in baseline hormone levels
between women. PA exposures that varied over the cycle were treated as time-varying
exposures in the analysis. In all four exposure models, 477 (12%) of the 3903 serum samples
were excluded due to observations missing data on perceived stress (n=15), time-varying PA
(n=354), or caloric intake (n=111). Models were performed using all available observations
for estradiol, FSH, testosterone, and leptin; only observations during the luteal and ovulatory
visits were assessed for progesterone and LH, respectively, because of their greatest
variation during these phases. Models were adjusted for age, BMI, race, and perceived
stress. Models of time-varying PA were also adjusted for habitual PA to examine acute PA
effects on hormone changes. Results of the models were presented as average percent
change in nontransformed reproductive hormone values relative to the lowest PA using the
following formula: {(exp^β)−1] × 100%}.
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For the time-varying analyses, we also estimated parameters using weighted models to
control for time-varying factors, such as caloric intake and reproductive hormones, which
could be both causes and consequences of time-varying PA. [26] We constructed inverse
probability weights using concurrent estradiol, progesterone, FSH, leptin, and caloric intake
measurements. These weights had a mean value of 1.00 with a range from 0.59 to 2.16.
The association between PA and sporadic anovulation was estimated using four PA
exposure definitions: 1) habitual PA; 2) past-week PA during the first half of the cycle; 3)
vigorous past-week PA during the first half of the cycle and 4) daily vigorous PA during the
first half of the cycle. Risk ratios (RR) were estimated using generalized linear models,
while adjusting for age, BMI, race, and perceived stress. For past-week and daily vigorous
PA, models were further adjusted for habitual PA and only included PA assessed prior to the
expected time of ovulation to preserve the proper temporal ordering of the exposure-
outcome relationship.
Bias analysis—For the association between time-varying past-week PA and estradiol
concentrations, error due to misclassification of MET-h/week was quantified using
probabilistic bias analysis. [27] We utilized a regression equation previously published from
a Women’s Health Initiative validation study that compared self-reported activity-related
energy expenditure with that from doubly-labeled water in 450 postmenopausal women.
[28] We used the validation study’s regression coefficients to calculate the correctly
classified MET-h/week for our study participants based on their age, race, BMI and self-
reported MET-h/week. Our study data was simulated 5000 times, with regression
coefficients selected by Monte Carlo sampling techniques to draw from a normal
distribution. [27, 29] Adjusted linear mixed regression models were applied to each
simulated dataset and sampling errors were incorporated (Rothman, Greenland, and Lash,
Modern Epidemiology III, page 366 equation 19–17). The 2.5th, 50th and 97.5th percentiles
of all simulations were reported.
RESULTS
Study population
Two-hundred and fifty nine women were followed for one (n=9) or two (n=250) menstrual
cycles. For women followed for two menstrual cycles, the majority had consecutive cycles
(92%; n=229) and the remaining 21 women had cycles that were, on average, two months
apart (mean=55, range 31 to 134 days). The average age of participants was 27.3 years
(standard deviation [SD], 8.2) and average BMI was 24.1 (SD, 3.9) (Table 1). Habitual and
daily vigorous PA varied by average past-week PA, with higher levels of activity in the
highest tertile of past-week PA; no other differences were observed.
The median past-week PA (averaged for each individual across the study) was 25 MET-h/
week (range 0 to 301), which is equivalent to approximately 7.5 hours of walking or 3 hours
of vigorous PA per week. Overall, past-week PA did not vary substantially across the
menstrual cycle (p= 0.08). However, PA was higher during the late luteal phase (assessed at
day 2) compared with the early luteal phase (assessed at day 22) (median 25 vs. 19 MET-h/
week, respectively, p= 0.01).
Menstrual cycle characteristics
Average follicular phase lengths differed by past-week PA averaged within each cycle
(p<0.01) with increasing lengths observed as PA increased (Table 2). No differences were
observed for the other menstrual cycle characteristics or the proportion of cycles that were
anovulatory.
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Hormone concentrations across a standardized 28-day menstrual cycle by past-week PA
averaged across each cycle are shown in Figure 1. Significant differences (p<0.05) were
observed for progesterone (day 7: middle < highest PA tertile); LH (days 7, 14, 18, 22:
lowest < highest PA tertile); and leptin (days 2, 7, 13, 18, 27: lowest > highest tertile; days
7, 14, 18: middle > highest tertile).
The associations between PA and changes in hormone concentrations across the menstrual
cycle are shown in Figure 2. Estradiol, ovulatory LH, and FSH concentrations were similar
between the highest and lowest PA levels, regardless of PA exposure definition. Luteal
progesterone was lower in the highest versus lowest PA levels for the three time-varying PA
exposure definitions (−22.1% for past-week PA [p= 0.02], −28.9% for vigorous past-week
PA [p<0.01], and −17.6% for daily vigorous PA [p<0.01]). Testosterone concentrations
were higher in the highest vigorous past-week PA tertile compared with the lowest tertile
(4.4%, p<0.01). Leptin concentrations were lower in the highest versus lowest levels among
the three time-varying PA assessments (−6.6% for past-week PA [p<0.01], −6.3% for
vigorous past-week PA [p<0.01], and −6.2% for daily vigorous PA [p<0.01]). The effects of
the middle versus lowest tertile of PA were, for the most part, either attenuated compared
with the highest PA level or imprecisely estimated (Supplementary Figure 1). Adjustment
for time-varying concurrent hormone concentrations and caloric intake had little impact on
the effect estimates, indicating that time-varying confounding by these factors was minimal
(data not shown). Probabilistic bias analysis revealed that correction for misclassification of
past-week PA resulted in a slightly stronger association between PA and estradiol, but the
confidence interval was wide and crossed the null (bias-corrected percent change= −3.4,
95% simulation interval [−13.6, 10.1]; conventionally adjusted percent change=−2.9, 95%
confidence interval [−9.4, 4.0]).
Sporadic anovulation
Cycles with high past-week PA during the first half of the cycle had a slightly higher risk of
sporadic anovulation compared with low PA, but this difference was not statistically
significant (Table 3). A similar finding was observed for daily vigorous PA during the first
half of the cycle. In contrast, habitual PA showed a lower risk of anovulation among the
highest PA tertile, but this confidence interval also crossed the null.
DISCUSSION
This study observed modest associations between time-varying PA and select reproductive
hormones among a cohort of healthy, premenopausal women. Specifically, high levels of PA
throughout the menstrual cycle were associated with lower concentrations of leptin and
luteal progesterone. Habitual PA, measured once at baseline, did not appear to be associated
with reproductive hormone concentrations. The risk of sporadic anovulation among this
cohort of regularly menstruating women was not significantly affected by PA level.
Previous observational studies of PA and hormones among reproductive-aged women have
found similar patterns for progesterone and leptin. In two multi-cycle studies, urinary
progesterone was lower, especially during the luteal phase, in recreational runners
(averaging 20 miles per week) and exercising women (averaging 7.5 hours of vigorous PA
per week) compared with sedentary women. [9, 12] In addition, numerous studies have also
found associations between acute increases in PA and decreases in leptin concentrations. [5,
30]
In contrast to previous studies, we found no association between PA and estradiol. Prior
observational studies have found that high levels of PA were associated with approximately
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10–20% lower urinary, [9, 11, 12] salivary, [10] and plasma estradiol concentrations
compared with the lowest PA group with PA measured by a variety of methods and findings
more pronounced for luteal phase estradiol. [13, 14] Experimental data also show decreased
estradiol concentrations following a 5-month exercise intervention. [31] Lower cumulative
estradiol concentrations have been proposed as an important mechanism for explaining the
protective association between PA and premenopausal breast cancer. [32]
Explanations for the discrepancy between our null findings and the inverse associations
observed for estradiol in previous studies are unclear, but could be due to differences in
methodology. In our study, PA was primarily measured using the IPAQ, while other studies
have used different questionnaire-based tools. Results from our post-hoc bias analysis
showed that misclassification of PA could have accounted for some, but not all, of our null
findings. Another explanation is that our study was restricted to regularly menstruating
women, which could have limited the comparability of our study population to the ones
previously examined. In fact, in these previous studies, attenuation of the PA-estradiol
association was observed after excluding women with menstrual cycle irregularities. [11, 13]
We also restricted our study to women with a BMI between 18 and 35; this likely enhanced
our ability to control for this confounder by design rather than introduced bias, but could
limit the generalizability of our findings.
This study expands on previous literature by examining the association between PA and
reproductive function using a prospective time-varying analysis that controls for changes in
concurrent hormones and caloric intake. Additional strengths of this study include the large
size of the cohort (259 women); the enumeration of two menstrual cycles for most
participants (97%); serum measures of hormones at five to eight time points across the
cycle, identified with the use of a fertility monitor; and the assessment of PA using both
validated questionnaires and daily diaries. [23]
This study has several limitations. Bio-measurements of PA using accelerometers or doubly
labeled water are more accurate than self-reported measures but were not used in this study.
[33] Although habitual PA was measured at baseline, participants were instructed to recall
PA over the previous 7 days, thus it may not reflect usual PA levels. Time-varying analyses
model the effect of consistently being within a particular PA tertile over time rather than the
effect within a defined group of women over time. This can limit the generalizability of the
findings as they pertain more to a hypothetical behavior than an individual’s actual behavior
pattern. The regression coefficients used for our bias analysis were estimated from
postmenopausal women and may have limited applicability to our premenopausal cohort,
however similar data in premenopausal women were not available. Ultrasound technology
could have provided a more accurate assessment of anovulatory cycles than our hormone-
based definition. In addition, we limited our ability to detect the risk of chronic anovulation
by excluding women with known ovulatory disorders and irregular menstrual cycle lengths.
In our cohort of healthy, moderate to highly active premenopausal women, PA did not
appear to substantially change hormone levels during the menstrual cycle or significantly
affect the risk of sporadic anovulation. These findings suggest that PA may not adversely
affect fecundability and further reinforce the beneficial effect of PA on women’s health.
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Refer to Web version on PubMed Central for supplementary material.
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Geometric mean hormone concentrations across a standardized 28-day menstrual cycle by
average past-week physical activity within each cycle: lowest tertile (median=9, maximum
=15 MET-h/week; solid line), middle tertile (median=24 MET-h/week; dashed line) and
highest tertile (median=66, minimum=37 MET-h/week; dotted line).
PA= physical activity; LH= luteinizing hormone; FSH= follicle-stimulating hormone
* P-value < 0.05; geometric means were estimated and p-values were assessed using
unadjusted linear mixed models. Significant differences were observed for progesterone
(day 7: middle < highest tertile); LH (days 7, 14, 18, 22: lowest < highest tertile); and leptin
(days 2, 7, 13, 18, 27: lowest > highest tertile; days 7, 14, 18: middle > highest tertile).
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The adjusted percent change in average hormone concentration for highest physical activity
(PA) compared to lowest PA for four exposure definitions of PA: habitual PA, time-varying
past-week PA, time-varying vigorous past-week PA and time-varying daily vigorous PA
(any vs. none).
LH= luteinizing hormone; FSH= follicle stimulating hormone; MET= metabolic equivalent;
PA= physical activity
The tertile cut-points were: 35.1 and 83.3 MET-h/week for habitual PA; 15.3 and 35.7
MET-h/week (on average) for time-varying past-week PA; and 1 and 15.5 MET-h/week (on
average) for time-varying vigorous past-week PA. All analyses adjusted for baseline
confounders; time-varying PA analyses were further adjusted for habitual PA and for
concurrent hormones and caloric intake using inverse probability weights.
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